News & Events

March 20, 2023

FDA Approves DAYBUE (Trofinetide) to Treat Rett Syndrome

Medication Will Be Available for Patients Two Years of Age and Older in April Acadia Pharmaceuticals Inc. recently announced that their medication, DAYBUETM (trofinetide) has gained approval from the U.S. Food and Drug Administration (FDA). DAYBUE is now the first and only drug approved for treating Rett Syndrome. The company expects the medication to be […]

March 20, 2023

Is Severe Autism Measured Adequately?

New Commentary Believes there’s a Better Way to Measure How the Condition Impacts Life A new commentary featured in the journal, Autism Research, calls for a more effective way of measuring severe autism that details specifically how an individual’s autism severity level impacts their life. Autism severity is currently defined and measured based exclusively on […]

March 13, 2023

Community Shares | March 13th 2023

UC Davis MIND Institute researchers have confirmed that brain development in people with autism varies from people without the disorder. According to their new study, these differences are associated with genes involved in inflammation, immune system response, and neural transmissions. These variations begin in childhood and progress throughout the lifespan. The study identified 194 significantly […]

March 13, 2023

Early Exposures to Phthalates Associated with ADHD Symptoms in Children with ASD

New Research Uses Data from the Childhood Autism Risks from Genetics and Environment (CHARGE) Study A new UC Davis MIND Institute study has found associations of phenol/parabens mixtures in urine samples of children with autism with increased ADHD symptoms, especially inattention. Predictably, these associations were more pronounced in males. The present study’s design included a […]

March 13, 2023

Prenatal Methylmercury Exposures Cause Autism-Like Behaviors in Rodents

Low-Dose Exposure Led to Impaired Communication, Reduced Sociability, and Repetitive Behaviors Canadian researchers have discovered that prenatal low-dose methylmercury (MeHg) exposure triggers autism-like behaviors in a rodent model. By studying adult mice that had been prenatally exposed to non-apoptotic (low dose) MeHg, the team noticed the mice exhibited key autism characteristics, including impaired communication, reduced […]

March 06, 2023

Community Shares | March 6th 2023

A recent research article indicates that children with ASD and GI symptoms have an immune system response imbalance that manifests in their circulating plasma cytokine levels. The author, Paul Ashwood, Ph.D., suggests that children with ASD and GI symptoms may be a subgroup of the disorder and that targeted treatments could be developed to help […]

Show Buttons
Hide Buttons